Biomarkers in Acute Kidney Injury
- PMID: 33752862
- DOI: 10.1016/j.ccc.2020.11.012
Biomarkers in Acute Kidney Injury
Abstract
Biomarkers have become a pillar of precision medicine in acute kidney injury (AKI). Traditional markers for diagnosis of AKI are insensitive and insufficient to provide comprehensive information for prognostication. Several emerging biomarkers have shown promising results in large-scale clinical studies. These novel markers likely will be beneficial for personalized AKI prevention and treatment.
Keywords: AKI; Biomarkers; CCL14; IGFBP7; NGAL; TIMP-2.
Copyright © 2020 Elsevier Inc. All rights reserved.
Conflict of interest statement
Disclosure N. Srisawat discloses grant support from Baxter. J.A. Kellum discloses grant support and consulting fees from Astute Medical, bioMérieux, and Baxter.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous
